Neuroptix, Inc. Obtains $18,500,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aec7c319-7bd5-4dac-ad7e-8f2c72f25e90&Preview=1 -
Date
10/22/2008 -
Company Name
Neuroptix, Inc. -
Mailing Address
20 Main Street Acton, MA 01720 -
Company Description
Neuroptix develops, manufactures and distributes state-of-the-art products for extremely sensitive measurements of biophysical changes in the eye, including non-invasive instruments for diagnosis and monitoring Alzheimer’s disease undergoing clinical development. Adaptable and innovative, Neuroptix’s products are designed for a variety of research environments including academic and pharmaceutical laboratories. Neuroptix is also developing diagnostic agents for application in screening tests for Alzheimer’s disease and prion diseases. -
Website
http://www.neuroptix.com -
Transaction Type
Venture Equity -
Transaction Amount
$18,500,000 -
Transaction Round
Series B -
Proceeds Purposes
Undisclosed -
M&A Terms
-
Venture Investor
Inventages Venture Capital -
Venture Investor
Undisclosed
